These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25743133)

  • 1. [Concurrent proton therapy and chemotherapy for locally advanced cancers].
    Ishikawa H; Fukumitsu N; Ohnishi K; Mizumoto M; Murofushi K; Numajiri H; Aihara T; Okumura T; Sakurai H
    Gan To Kagaku Ryoho; 2015 Feb; 42(2):148-53. PubMed ID: 25743133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proton beam therapy with concurrent chemotherapy for non-small cell lung cancer -- our experiences and future direction].
    Niho S; Motegi A; Akimoto T
    Gan To Kagaku Ryoho; 2015 Feb; 42(2):144-7. PubMed ID: 25743132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy with charged particles.
    Schulz-Ertner D; Jäkel O; Schlegel W
    Semin Radiat Oncol; 2006 Oct; 16(4):249-59. PubMed ID: 17010908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status of particle therapy for lung cancer.
    Liao Z; Lin SH; Cox JD
    Acta Oncol; 2011 Aug; 50(6):745-56. PubMed ID: 21767170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton beam therapy combined with concurrent chemotherapy for esophageal cancer.
    Ishikawa H; Hashimoto T; Moriwaki T; Hyodo I; Hisakura K; Terashima H; Ohkohchi N; Ohno T; Makishima H; Mizumoto M; Ohnishi K; Okumura T; Sakurai H
    Anticancer Res; 2015 Mar; 35(3):1757-62. PubMed ID: 25750339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cancer therapy using particle radiation].
    Tsunemoto H
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):394-401. PubMed ID: 6309087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proton beam therapy].
    Kitagawa T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):878-84. PubMed ID: 3008670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical physics aspects of particle therapy.
    Jäkel O
    Radiat Prot Dosimetry; 2009 Nov; 137(1-2):156-66. PubMed ID: 19828718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heavy charged particle radiotherapy--proton beam].
    Ogino T
    Gan To Kagaku Ryoho; 2003 Dec; 30(13):2030-5. PubMed ID: 14712761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term cosmetic outcomes and toxicities of proton beam therapy compared with photon-based 3-dimensional conformal accelerated partial-breast irradiation: a phase 1 trial.
    Galland-Girodet S; Pashtan I; MacDonald SM; Ancukiewicz M; Hirsch AE; Kachnic LA; Specht M; Gadd M; Smith BL; Powell SN; Recht A; Taghian AG
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):493-500. PubMed ID: 24880212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proton beam therapy at Shizuoka Cancer Center].
    Murayama S; Fuji H
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1806-12. PubMed ID: 19920382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
    Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
    Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of the cost and cost-effectiveness studies of proton radiotherapy.
    Verma V; Mishra MV; Mehta MP
    Cancer; 2016 May; 122(10):1483-501. PubMed ID: 26828647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proton beam therapy combined with chemotherapy for advanced cancer].
    Fuwa N
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1385-9. PubMed ID: 21918332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-comparativeness of proton versus photon therapy.
    Verma V; Shah C; Rwigema JC; Solberg T; Zhu X; Simone CB
    Chin Clin Oncol; 2016 Aug; 5(4):56. PubMed ID: 27506804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
    Palm A; Johansson KA
    Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent chemoradiotherapy using proton beams can reduce cardiopulmonary morbidity in esophageal cancer patients: a systematic review.
    Nonaka T; Kawashiro S; Ishikawa H; Ito Y; Nemoto K; Ishihara R; Oyama T; Oyama T; Kato K; Kato H; Kawakubo H; Kawachi H; Kuribayashi S; Kono K; Kojima T; Takeuchi H; Tsushima T; Toh Y; Booka E; Makino T; Matsuda S; Matsubara H; Mano M; Minashi K; Miyazaki T; Muto M; Yamaji T; Yamatsuji T; Yoshida M; Kitagawa Y;
    Esophagus; 2023 Oct; 20(4):605-616. PubMed ID: 37328706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton beam therapy for hepatocellular carcinoma.
    Yeung RH; Chapman TR; Bowen SR; Apisarnthanarax S
    Expert Rev Anticancer Ther; 2017 Oct; 17(10):911-924. PubMed ID: 28825506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproton radiotherapy.
    Bassler N; Alsner J; Beyer G; DeMarco JJ; Doser M; Hajdukovic D; Hartley O; Iwamoto KS; Jäkel O; Knudsen HV; Kovacevic S; Møller SP; Overgaard J; Petersen JB; Solberg TD; Sørensen BS; Vranjes S; Wouters BG; Holzscheiter MH
    Radiother Oncol; 2008 Jan; 86(1):14-9. PubMed ID: 18158194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.